Research Studies

OleoCBD™ Bioaccessability Study


When compared against CBD isolate our Micro-Encapsulated OleoCBD™ is 4-5x more bioaccessible when measured over the first two hours after consumption.

This test was conducted using a dynamic model of the upper gastrointestinal tract (TIM-1 test). It compares the bioaccessibility rates of different compounds in a scientific manner. The test concluded that each milligram of OleoCBD™ is 4-5x more bioaccessible than CBD isolate over the initial 2-hour period and 2x more bioaccessible over the full course of the model (5 hours). On pages 9 and 17 you’ll find pictures of the machine used to conduct the test as well as charts comparing the bioaccessibility rates over time.

OLEO Bioaccessability Study - OleoCBD Bioaccessibility 10-08-18